Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Gliolan Aminolevulinic acid hydrochloride 1.5g Powder for oral solution Specialised Therapeutics Limited IDT Biologika GmbH, Dessau Rosslau, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Inflectra Infliximab 100mg Powder for injection Pharmbio Pty Limited Mustafa Nevzat llac Sanayii A.S., Istanbul, Turkey
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Kevtam Levetiracetam 250mg Film coated tablet Mylan New Zealand Limited Mylan Pharmaceuticals Inc, West Virginia, United States of America
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Kevtam Levetiracetam 500mg Film coated tablet Mylan New Zealand Limited Mylan Pharmaceuticals Inc, West Virginia, United States of America
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Kevtam Levetiracetam 750mg Film coated tablet Mylan New Zealand Limited Mylan Pharmaceuticals Inc, West Virginia, United States of America
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Kevtam Levetiracetam 1000mg Film coated tablet Mylan New Zealand Limited Mylan Pharmaceuticals Inc, West Virginia, United States of America
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Remsima Infliximab 100mg Powder for injection Pharmbio Pty Limited Mustafa Nevzat llac Sanayii A.S., Istanbul, Turkey
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Tramadol Actavis Tramadol hydrochloride 50mg/mL Solution for injection Actavis New Zealand Limited Laboratorios Norman SA, Madrid, Spain
|
Dated this 11th day of September 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).